These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 10773323

  • 1. Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis.
    Sung KC, Fang JY, Hu OY.
    J Control Release; 2000 Jun 15; 67(1):1-8. PubMed ID: 10773323
    [Abstract] [Full Text] [Related]

  • 2. Transdermal delivery of nalbuphine and nalbuphine pivalate from hydrogels by passive diffusion and iontophoresis.
    Fang JY, Sung KC, Hu OY, Chen HY.
    Arzneimittelforschung; 2001 Jun 15; 51(5):408-13. PubMed ID: 11413742
    [Abstract] [Full Text] [Related]

  • 3. Transdermal delivery of nalbuphine and its prodrugs by electroporation.
    Sung KC, Fang JY, Wang JJ, Hu OY.
    Eur J Pharm Sci; 2003 Jan 15; 18(1):63-70. PubMed ID: 12554074
    [Abstract] [Full Text] [Related]

  • 4. The effects of electrically assisted methods on transdermal delivery of nalbuphine benzoate and sebacoyl dinalbuphine ester from solutions and hydrogels.
    Huang JF, Sung KC, Hu OY, Wang JJ, Lin YH, Fang JY.
    Int J Pharm; 2005 Jun 13; 297(1-2):162-71. PubMed ID: 15907603
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: mechanism of stereoselective permeation.
    Ahmed S, Imai T, Otagiri M.
    Pharm Res; 1996 Oct 13; 13(10):1524-9. PubMed ID: 8899845
    [Abstract] [Full Text] [Related]

  • 6. Transdermal delivery of atenolol: effect of prodrugs and iontophoresis.
    Anroop B, Ghosh B, Parcha V, Khanam J.
    Curr Drug Deliv; 2009 Jul 13; 6(3):280-90. PubMed ID: 19604142
    [Abstract] [Full Text] [Related]

  • 7. Biodegradable polymeric microspheres for nalbuphine prodrug controlled delivery: in vitro characterization and in vivo pharmacokinetic studies.
    Liu FI, Kuo JH, Sung KC, Hu OY.
    Int J Pharm; 2003 May 12; 257(1-2):23-31. PubMed ID: 12711158
    [Abstract] [Full Text] [Related]

  • 8. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM, Corish J, Corrigan OI, Fitzpatrick D.
    Int J Pharm; 2007 Aug 16; 341(1-2):114-24. PubMed ID: 17502130
    [Abstract] [Full Text] [Related]

  • 9. Ester prodrugs of morphine improve transdermal drug delivery: a mechanistic study.
    Wang JJ, Sung KC, Huang JF, Yeh CH, Fang JY.
    J Pharm Pharmacol; 2007 Jul 16; 59(7):917-25. PubMed ID: 17637185
    [Abstract] [Full Text] [Related]

  • 10. Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability.
    Chen Y, Alberti I, Kalia YN.
    Eur J Pharm Biopharm; 2016 Feb 16; 99():103-13. PubMed ID: 26686649
    [Abstract] [Full Text] [Related]

  • 11. Ionized prodrugs of dehydroepiandrosterone for transdermal iontophoretic delivery.
    Laneri S, Sacchi A, di Frassello EA, Luraschi E, Colombo P, Santi P.
    Pharm Res; 1999 Dec 16; 16(12):1818-24. PubMed ID: 10644068
    [Abstract] [Full Text] [Related]

  • 12. Improvement of nalbuphine bioavailability through rectal administration of a prodrug.
    Chang RK, Hussain MA.
    Pharm Dev Technol; 1998 Feb 16; 3(1):131-4. PubMed ID: 9532608
    [No Abstract] [Full Text] [Related]

  • 13. In vitro study of transdermal penetration and iontophoresis of hepatitis B vaccines through rat skin.
    Xu T, Xu YH, Wei MY, Deng LH, Wu CB.
    Yao Xue Xue Bao; 2011 Jun 16; 46(6):713-9. PubMed ID: 21882534
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery.
    Doh HJ, Cho WJ, Yong CS, Choi HG, Kim JS, Lee CH, Kim DD.
    J Pharm Sci; 2003 May 16; 92(5):1008-17. PubMed ID: 12712420
    [Abstract] [Full Text] [Related]

  • 15. Passive and iontophoretic permeation of glipizide.
    Jain A, Ghosh B, Rajgor N, Desai BG.
    Eur J Pharm Biopharm; 2008 Aug 16; 69(3):958-63. PubMed ID: 18291633
    [Abstract] [Full Text] [Related]

  • 16. The effects of iontophoresis and electroporation on transdermal delivery of buprenorphine from solutions and hydrogels.
    Fang JY, Sung KC, Wang JJ, Chu CC, Chen KT.
    J Pharm Pharmacol; 2002 Oct 16; 54(10):1329-37. PubMed ID: 12396293
    [Abstract] [Full Text] [Related]

  • 17. Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies.
    Kim BY, Doh HJ, Le TN, Cho WJ, Yong CS, Choi HG, Kim JS, Lee CH, Kim DD.
    Int J Pharm; 2005 Apr 11; 293(1-2):193-202. PubMed ID: 15778057
    [Abstract] [Full Text] [Related]

  • 18. Transdermal iontophoresis of sodium nonivamide acetate. V. Combined effect of physical enhancement methods.
    Fang JY, Hwang TL, Huang YB, Tsai YH.
    Int J Pharm; 2002 Mar 20; 235(1-2):95-105. PubMed ID: 11879744
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of salicylic acid fatty ester prodrugs for UV protection.
    Im JS, Balakrishnan P, Oh DH, Kim JS, Jeon EM, Kim DD, Yong CS, Choi HG.
    Drug Dev Ind Pharm; 2011 Jul 20; 37(7):841-8. PubMed ID: 21244220
    [Abstract] [Full Text] [Related]

  • 20. Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs.
    Wang JJ, Sung KC, Hu OY, Yeh CH, Fang JY.
    J Control Release; 2006 Oct 10; 115(2):140-9. PubMed ID: 16959357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.